Skip to main content

Table 2 Candidate mitochondrial genes and complexes for each cancer type

From: Cancerouspdomains: comprehensive analysis of cancer type-specific recurrent somatic mutations in proteins and domains

Cancer Type Genes (Percentage) Complexes (Percentage)
ACC MT-TL1 (32.6) -
BRCA MT-RNR1 (3.6), MT-RNR2 (5.6), MT-TT (0.8) rRNA (8.4)
CHOL MT-RNR2 (33.3) rRNA (33.3)
ESCA MT-CYB (13.7) COMPLEX III (13.7)
HNSC MT-ND5 (1) -
KICH MT-ND1 (13.6) -
LIHC MT-ND5 (12.9) COMPLEX I (18.3)
LUAD - COMPLEX III (1.1)
PRAD MT-RNR2 (1.9) -
SARC MT-RNR2 (12.6), MT-CO2 (7.1) rRNA (14.2), COMPLEX IV (15.7)
TGCT - COMPLEX III (6.3)
THYM MT-RNR2 (27.6) rRNA (27.6)
UCEC MT-RNR1 (11.7), MT-RNR2 (11.7), MT-TV (12) rRNA (0.41.7)
Pan Cancer MT-RNR2, MT-CYB rRNA, COMPLEX III